薬物乱用検査の世界市場予測

◆英語タイトル:Global Drug Abuse Testing Market Development and Demand Research Report- Forecast to 2020
◆商品コード:MRF6120206
◆発行会社(調査会社):Market Research Future
◆発行日:2016年10月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可)USD4,450 ⇒換算¥502,850見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD6,250 ⇒換算¥706,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Research Future社の日本における正規販売代理店です。Market Research Future社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

Report DescriptionIntroduction
Drug of abuse testing is based on diagnosing drug addiction, also called substance use disorder, requiring a thorough evaluation and often includes an assessment by a psychiatrist, a psychologist, or a licensed alcohol and drug counselor. Blood, urine or other lab tests are used to assess drug use, but they’re not a diagnostic test for addiction. These tests may be used for monitoring treatment.
This report contains an analysis of drug of abuse testing market based on the type of test conducted, sample used for testing and geographical analysis, with a brief on testing technologies. The testing technologies consist of immunoassay technique and chromatography technique, used for both onsite as well as laboratory testing.
The global drug abuse testing market is expected to reach $3.8 billion by 2020 at a CAGR of 5.3% during the forecast period.
On the basis of type of tests, onsite testing is by far the fastest growing segment of global drug abuse testing market and it is expected to reach $2.8 billion by 2020. .
Based on type of samples, urine samples commands largest market share of global drug abuse testing market and it is expected to grow at a CAGR of 5.1% during the period 2016 to 2020.
The use of illicit drugs is rising every year globally and has become a big concern for countries including the U.S., the U.K. Japan, Germany, India and China. Illicit drugs in use include heroin, cannabis, cocaine, ecstasy and amphetamine. For instance, global cocaine seizures increased to 671 tons in 2012, compared with the 634 tons seized in 2011.
The main increase in the quantities of cocaine seized was in South America and Western and Central Europe. These factors are preliminarily driving the growth of drug abuse testing market globally. Currently, one of the major challenges market is facing is legalization of drugs, Social issues associated with drug abuse testing, are limiting the growth of global drug abuse testing market at a greater extent.
North America was the largest market by geography for drug abuse testing in 2014, with 76.4% share of the total market, followed by Europe with a 16.4% share and Asia with a 4.7% share of the total market.
Key Players
The leading market players in the global drug abuse testing market include; Roche Holding Limited (Switzerland), Quest Diagnostics (U.S.), Laboratory Corporation of America Holdings (U.S.), Alere Inc. (U.S.), Abbott Laboratories (U.S.), Randox Laboratories Ltd (U.K.), Psychemedics Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and others.  
Study Objectives of Drug Abuse Testing Market Development and Demand Forecast to 2020 Market
 To provide insights about factors, influencing and affecting the market growth.
 To provide historical and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries.
 To provide historical and forecast revenue of the market segments based on type of test, and type of sample for global drug abuse testing market.
 To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.
 To provide economic factors that influences the global drug abuse testing market.

Target Audience
• Pharmaceutical companies
• Forensic laboratories
• Research Laboratories
• Hospitals & Clinics
• Component and Raw Material Suppliers
• Service Suppliers
• Potential Investors
• Key executive (CEO and COO) and strategy growth manager

Key Findings
• The global market for drug abuse testing is expected to grow at a CAGR of 5.3% during the period 2016 to 2020 to reach $3.8 billion by 2020.
• The Asian and Europe drug abuse testing market is expected to grow rapidly during 2016 to 2020; whereas, North America will remain the largest market by 2020.
• By type of tests, onsite testing segment is expected to witness highest CAGR of 5.9% during the period 2016 to 2020.
• Based on the type of samples, urine sample segment commands the largest market share of global drug abuse testing market; registered 87% share in 2015
• Abbott Laboratories (U.S.), Roche Holding Limited (Switzerland), Quest Diagnostics (U.S.), are so far the leading market players for drug abuse testing market globally

Regional and Country Analysis of Drug Abuse Testing Market Development and Demand Forecast to 2020 Market
As per the MRFR analysis, the Asia drug abuse testing market is poised to reach $160 million by 2020, to grow at a CAGR of around XX% during the forecasted period. European market was valued at $ 494.6 million in 2015, and expected to reach at $ 595 million by 2020. North America continues to be the leading region during the forecast period.
The reports also cover country level analysis:
• North America
o US
o Canada
• Europe
o Germany
o U.K.
o Italy
o Spain
o France
o Rest of Western Europe
o Eastern Europe
• Asia-Pacific
o Japan
o China
o India
o Republic of Korea
o Rest of Asia-Pacific

【レポートの目次】

CHAPTER 1.RESEARCH SCOPE & METHODOLOGY 10
1.1 MARKET DEFINITION 10
1.2 MARKET BREAKDOWN BY TYPE OF TESTS, SAMPLE 10
1.3 MARKET BREAKDOWN BY GEOGRAPHY 11
1.4 RESEARCH METHODOLOGY AND SOURCES 11
CHAPTER 2.EXECUTIVE SUMMARY 13
2.1 KEY FINDINGS 13
2.2 RESEARCH SUMMARY 13
CHAPTER 3.MARKET OUTLOOK 15
3.1 INTRODUCTION 15
3.1.1INTERNATIONAL DRUG TRAFFICKING 15
3.1.2 DRUG TRAFFICKING AND ILLICIT DRUG USE IN NORTH AMERICA 16
3.1.3DRUG TRAFFICKING AND ILLICIT DRUG USE IN EUROPE 16
3.1.4DRUG TRAFFICKING AND ILLICIT DRUG USE IN ASIA-PACIFIC 16
3.2 TECHNOLOGY ANALYSIS – DRUG ABUSE TESTING MARKET 17
3.2.1CHROMATOGRAPHY TECHNOLOGY 17
3.2.2IMMUNOASSAY TECHNOLOGY 17
3.3 SINGLE VIS-À-VIS MULTIPLE PARAMETER TEST 18
3.4 FACTORS DRIVING THE MARKET AND ITS IMPACT ON MARKET FORECAST 19
3.4.1 INCREASED USE OF DRUG TESTING AT ORGANIZATIONAL LEVEL 19
3.4.2INCREASED PRODUCTION AND TRADE OF ILLICIT DRUGS WORLDWIDE 20
3.4.3GLOBAL INCREASE IN ROAD ACCIDENTS AND DEATH RATES 20
3.4.4INCREASE IN THE CONSUMPTION OF ILLEGAL DRUGS 20
3.4.5IMPACT ANALYSIS OF DRIVERS ON MARKET FORECAST 21
3.5 FACTORS HINDERING THE MARKET AND ITS IMPACT ON MARKET FORECAST 21
3.5.1LEGALIZATION OF DRUGS 21
3.5.2SOCIAL ISSUES ASSOCIATED WITH DRUG ABUSE TESTING 22
3.5.3INABILITY OF TESTING PRODUCTS TO DETECT LOW-DOSE DESIGNER DRUGS 22
3.5.4IMPACT ANALYSIS OF RESTRAINTS ON MARKET FORECAST 23
CHAPTER 4.GLOBAL MARKET SIZE & FORECAST (2011-2020) 24
4.1 GLOBAL MARKET BREAKDOWN BY TYPE OF TEST 24
4.2 GLOBAL MARKET BREAKDOWN BY SAMPLE 25
4.3 GLOBAL MARKET BREAKDOWN BY REGION 27
CHAPTER 5.GLOBAL MARKET BREAKDOWN BY TYPE OF TEST 29
5.1 ONSITE TESTING 29
5.2 LABORATORY TESTING 29
5.3 THE NORTH AMERICAN MARKET BY TYPE OF TEST 30
5.3.1U.S. DRUGS OF ABUSE MARKET BY TYPE OF TEST 32
5.4 THE EUROPEAN MARKET BY TYPE OF TEST 33
5.4.1THE U.K. DRUGS OF ABUSE MARKET, BY TYPE OF TEST 34
5.4.2GERMANY DRUGS OF ABUSE MARKET BY TYPE OF TEST 34
5.4.3FRANCE DRUGS OF ABUSE MARKET, BY TYPE OF TEST 35
5.5 THE ASIAN MARKET BY TYPE OF TEST 36
5.5.1INDIA DRUGS OF ABUSE MARKET BY TYPE OF TEST 37
5.5.2CHINA DRUGS OF ABUSE MARKET, BY TYPE OF TEST 38
5.5.3JAPAN DRUGS OF ABUSE MARKET, BY TYPE OF TEST 38
CHAPTER 6.GLOBAL MARKET BREAKDOWN BY SAMPLE 40
CHAPTER 7.GLOBAL MARKET BREAKDOWN BY REGION 43
7.1 NORTH AMERICA MARKET BREAKDOWN BY COUNTRY 43
7.1.1DRUG ABUSE MARKET SCENARIO IN THE U.S. 44
7.2 EUROPE MARKET BREAKDOWN BY COUNTRY 45
7.2.1DRUG ABUSE MARKET SCENARIO IN THE U.K. 46
7.2.2DRUG ABUSE MARKET SCENARIO IN FRANCE 46
7.2.3DRUG ABUSE MARKET SCENARIO IN GERMANY 47
7.3 ASIA-PACIFIC MARKET BREAKDOWN BY COUNTRY 47
7.3.1DRUG ABUSE MARKET SCENARIO IN INDIA 49
7.3.2DRUG ABUSE MARKET SCENARIO IN CHINA 50
7.3.3DRUG ABUSE MARKET SCENARIO IN JAPAN 51
CHAPTER 8.COMPETITIVE ANALYSIS AND MARKET SHARE 52
8.1 PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS 52
8.1.1BARGAINING POWER OF BUYERS 52
8.1.2BARGAINING POWER OF SUPPLIERS 53
8.1.3THREAT OF NEW ENTRANTS 53
8.1.4INTENSITY OF RIVALRY 53
8.1.5THREAT OF SUBSTITUTES 53
CHAPTER 9.COMPANY PROFILES 54
9.1 ROCHE HOLDING LIMITED 54
9.1.1BUSINESS OVERVIEW 54
9.1.2PRODUCTS AND SERVICES 54
9.1.3RECENT DEVELOPMENTS 55
9.2 QUEST DIAGNOSTICS 55
9.2.1BUSINESS OVERVIEW 55
9.2.2PRODUCTS AND SERVICES 56
9.2.3RECENT DEVELOPMENTS 56
9.3 LABORATORY CORPORATION OF AMERICA HOLDINGS 56
9.3.1BUSINESS OVERVIEW 57
9.3.2PRODUCTS AND SERVICES 57
9.3.3RECENT DEVELOPMENTS 57
9.4 ALERE INC. 58
9.4.1BUSINESS OVERVIEW 58
9.4.2PRODUCTS AND SERVICES 58
9.4.3RECENT DEVELOPMENTS 58
9.5 ABBOTT LABORATORIES 59
9.5.1BUSINESS OVERVIEW 59
9.5.2PRODUCTS AND SERVICES 59
9.5.3RECENT DEVELOPMENTS 60
9.6 RANDOX LABORATORIES LTD 60
9.6.1BUSINESS OVERVIEW 60
9.6.2PRODUCTS AND SERVICES 61
9.6.3RECENT DEVELOPMENTS 62
9.7 PSYCHEMEDICS CORPORATION 62
9.7.1BUSINESS OVERVIEW 62
9.7.2PRODUCTS AND SERVICES 62
9.7.3RECENT DEVELOPMENTS 62
9.8 BIO-RAD LABORATORIES, INC. 63
9.8.1BUSINESS OVERVIEW 63
9.8.2PRODUCTS AND SERVICES 63
9.8.3RECENT DEVELOPMENTS 63
9.9 SONIC HEALTHCARE 64
9.9.1BUSINESS OVERVIEW 64
9.9.2PRODUCTS AND SERVICES 64
9.9.3RECENT DEVELOPMENTS 65
9.10THERMO FISHER SCIENTIFIC INC. 66
9.10.1BUSINESS OVERVIEW 66
9.10.2PRODUCTS AND SERVICES 66
9.10.3RECENT DEVELOPMENTS 67
CHAPTER 10.APPENDIX 68
10.1LIST OF ABBREVIATIONS 68

TABLE 1 SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION 12
TABLE 2 GLOBAL DRUG ABUSE TESTING MARKET SNAPSHOT(2015AND 2020) 14
TABLE 3 WORLDWIDE NUMBER OF ILLICIT DRUG USERS, BY MAJOR DRUGS, % SHARE(2011) 15
TABLE 4 MULTIPLE PARAMETER TEST ADVANTAGES OVER SINGLE PARAMETER TEST 19
TABLE 5 DRIVERS FOR THE MARKET: IMPACT ANALYSIS 21
TABLE 6 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS 23
TABLE 7 GLOBAL MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014) 24
TABLE 8 GLOBAL MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020) 25
TABLE 9 GLOBAL MARKET BREAKDOWN BY SAMPLE, $M (2011 – 2014) 26
TABLE 10 GLOBAL MARKET BREAKDOWN BY SAMPLE, $M (2015 – 2020) 26
TABLE 11 GLOBAL MARKET BREAKDOWN BY REGION, $M (2011 – 2014) 27
TABLE 12 GLOBAL MARKET BREAKDOWN BY REGION, $M (2015 – 2020) 28
TABLE 13 ONSITE SCREENING TEST – ADVANTAGES AND DISADVANTAGES 29
TABLE 14 LABORATORY DRUG TEST - ADVANTAGES AND DISADVANTAGES 30
TABLE 15 NORTH AMERICA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014) 31
TABLE 16 NORTH AMERICA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020) 31
TABLE 17 U.S. MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014) 32
TABLE 18 U.S. MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020) 32
TABLE 19 EUROPE MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014) 33
TABLE 20 EUROPE MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020) 33
TABLE 21 THE U.K. MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014) 34
TABLE 22 THE U.K. MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020) 34
TABLE 23 GERMANY MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014) 35
TABLE 24 GERMANY MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020) 35
TABLE 25 FRANCE MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014) 35
TABLE 26 FRANCE MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020) 36
TABLE 27 ASIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014) 36
TABLE 28 ASIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020) 36
TABLE 29 INDIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014) 37
TABLE 30 INDIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020) 37
TABLE 31 CHINA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014) 38
TABLE 32 CHINA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020) 38
TABLE 33 JAPAN MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014) 39
TABLE 34 JAPAN MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020) 39
TABLE 35 SAMPLE ANALYSIS – ADVANTAGES AND DISADVANTAGES 40
TABLE 36 NORTH AMERICA MARKET BREAKDOWN BY REGION, $M (2011 – 2014) 43
TABLE 37 NORTH AMERICA MARKET BREAKDOWN BY REGION, $M (2015 – 2020) 44
TABLE 38 EUROPE MARKET BREAKDOWN BY REGION, $M (2011 – 2014) 45
TABLE 39 EUROPE MARKET BREAKDOWN BY REGION, $M (2015 – 2020) 46
TABLE 40 ASIA MARKET BREAKDOWN BY REGION, $M (2011 – 2014) 49
TABLE 41 ASIA MARKET BREAKDOWN BY REGION, $M (2015 – 2020) 49
TABLE 42 ROCHE HOLDINGS – KEY FACTS 54
TABLE 43 QUEST DIAGNOSTICS – KEY FACTS 55
TABLE 44 LABORATORY CORPORATION OF AMERICA HOLDINGS – KEY FACTS 56
TABLE 45 ALEREINC. – KEY FACTS 58
TABLE 46 ABBOTT LABORATORIES – KEY FACTS 59
TABLE 47 RANDOX LABORATORIES – KEY FACTS 60
TABLE 48 PSYCHEMEDICS CORPORATION – KEY FACTS 62
TABLE 49 BIO-RAD LABORATORIES – KEY FACTS 63
TABLE 50 SONIC HEALTHCARE – KEY FACTS 64
TABLE 51 THERMO FISHER SCIENTIFIC INC.– KEY FACTS 66


FIG 1 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2014) 24
FIG 2 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY SAMPLE (2014) 25
FIG 3 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY REGION (2014) 27
FIG 4 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2014) 30
FIG 5 THE NORTH AMERICAN DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2015) 31
FIG 6 THE EUROPEAN DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2015) 33
FIG 7 THE ASIAN DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST, 2015 37
FIG 8 GLOBAL DRUG ABUSE TESTING MARKET SHARE, BY SAMPLE, 2015 42
FIG 9 NORTH AMERICA DRUG ABUSE TESTING MARKET SHARE BY COUNTRY(2014) 43
FIG 10 EUROPE DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2014) 45
FIG 11 ASIA-PACIFIC DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2014) 48
FIG 12 PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS 52


【掲載企業】

Roche Holding Limited (Switzerland), Quest Diagnostics (U.S.), Laboratory Corporation of America Holdings (U.S.), Alere Inc. (U.S.), Abbott Laboratories (U.S.), Randox Laboratories Ltd (U.K.), Psychemedics Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and others

【レポートのキーワード】

薬物乱用検査

★調査レポート[薬物乱用検査の世界市場予測] (コード:MRF6120206)販売に関する免責事項を必ずご確認ください。
★調査レポート[薬物乱用検査の世界市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆